321 ARSENAL STREET, SUITE 101, WATERTOWN, MA
Financial Results, Press Release
Material disclosure
Election of Class III Directors at 2026 Annual Meeting of Stockholders
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Restructuring Plan Approved; 20% Workforce Reduction at Disc Medicine
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Investor Presentation
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report